Formulary Search Results for: CALCIUM AND VITAMIN D
6.4.2 Male sex hormones and antagonists - View Category
3.5.1 Respiratory stimulants - View Category
5.1.3 Tetracyclines - View Category
Prescribing Notes:
Doxycycline is no more effective than oxytetracycline and is several times more expensive. Uses include sinusitis and pelvic inflammatory disease.
5.3.1.1 Nucleoside reverse transcriptase inhibitors - View Category
Restrictions:
Restricted to use by HIV specialists.
Prescribing Notes:
For treatment of hepatitis B see section 5.3.3.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
Restricted to use by HIV specialists.
Prescribing Notes:
Please note: Only this combination preparation containing cobicistat is included in the Formulary. Cobicistat tablets as a separate preparation (Tybost®) are not recommended for use by the Scottish Medicines Consortium and are non-Formulary.
4.1.1.1 Hypnotics for acute insomnia - View Category
4.1.2 Anxiolytics - View Category
4.3.4 Other antidepressant drugs - View Category
Restrictions:
Restricted to psychiatrist initiation only as a third line therapy for major depressive episodes. The SMC has not recommended its use for generalised anxiety disorders.
4.6 Drugs used in nausea and vertigo - View Category
Restrictions:
Restricted to use by consultant anaesthetists for use as a third line antiemetic for PONV in patients with previous failure of other formulary agents. This preparation should only be routinely held in theatre recovery areas for this indication. The use of droperidol for addition to a PCA containing opiates remains non-Formulary.
4.6 Drugs used in nausea and vertigo - View Category
Prescribing Notes:
In April 2014, following a Europe-wide review, the MHRA issued advice to healthcare professionals relating to the use of domperidone, restricting its use to relief or nausea and vomiting, advising that it should be used at the lowest effective dose for the shortest possible time, and highlighting changes to the contraindications, dosing and duration of treatment of the medicine.
The full advice from the MHRA can be accessed here.